BioCentury | Oct 23, 2014
Distillery Therapeutics

Indication: Endocrine/metabolic disease

...fasting blood glucose levels and increased glucose tolerance and insulin sensitivity compared with no supplementation. Mito BioPharm LLC...
...of niclosamide ethanolamine. SciBX 7(41); doi:10.1038/scibx.2014.1207 Published online Oct. 23, 2014 Patent pending; licensed to Mito BioPharm...
Items per page:
1 - 1 of 1
BioCentury | Oct 23, 2014
Distillery Therapeutics

Indication: Endocrine/metabolic disease

...fasting blood glucose levels and increased glucose tolerance and insulin sensitivity compared with no supplementation. Mito BioPharm LLC...
...of niclosamide ethanolamine. SciBX 7(41); doi:10.1038/scibx.2014.1207 Published online Oct. 23, 2014 Patent pending; licensed to Mito BioPharm...
Items per page:
1 - 1 of 1